SOPitis [Design Issues]

posted by mittyri  – Russia, 2014-02-26 20:23 (4497 d 10:46 ago) – Posting: # 12520
Views: 7,063

Hi ElMaestro & all!

❝ I think I would word the protocol and study title carefully. The study is not really randomised if some randomisations are better than others. This is when I think stratification must be part of the wording.


Could you give an example of wording?
"Multicentre, single-dose, randomised, open label, two-sequence, two-period, crossover, bioavailability study in male and female patients under fed conditions with gender stratification" - something like that?

Would stratification be applicable in BEQ studies from assessors point of view? Any experience?

Kind regards,
Mittyri

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,570 registered users;
129 visitors (0 registered, 129 guests [including 20 identified bots]).
Forum time: 08:10 CEST (Europe/Vienna)

Science is simply common sense at its best that is,
rigidly accurate in observation, and
merciless to fallacy in logic.    Thomas Henry Huxley

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5